Share
Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers (in English)
Penny Hill Press
(Illustrated by)
·
Createspace Independent Publishing Platform
· Paperback
Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers (in English) - Penny Hill Press ; Food and Drug Administration
$ 11.96
$ 14.95
You save: $ 2.99
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Monday, July 08 and
Tuesday, July 09.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers (in English)"
This guidance provides information for industry, researchers, physicians, institutional review boards (IRBs), and patients about the implementation of FDA's regulations on expanded access to investigational drugs for treatment use under an investigational new drug application (IND) (21 CFR part 312, subpart I), which went into effect on October 13, 2009. Since 2009, FDA has received a number of questions concerning implementation of the regulations. As a result, FDA is providing guidance in a question and answer format, addressing the most frequently asked questions. In a separate guidance, FDA provides answers to questions concerning the implementation of the regulation on charging for investigational drugs under an IND (21 CFR 312.8). Also in a separate guidance, FDA describes Form FDA 3926 (Individual Patient Expanded Access-Investigational New Drug Application (IND)) and the process for submitting expanded access requests for individual patient INDs
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.